Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
14,22 USD | -1,25% | +2,89% | -5,20% |
Métier
Nombre d'employés: 200
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
RTGel Reverse-Thermal Hydrogel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 64 | 100,0 % | 83 | 100,0 % | +28,52% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 62 | 03/01/19 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 01/08/21 |
Jason Smith
CMP | Compliance Officer | 52 | 09/09/20 |
Marina Konorty
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/11 |
Moran Mieron
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mark Schoenberg
CTO | Chief Tech/Sci/R&D Officer | 66 | 09/02/16 |
Investor Relations Contact | - | 01/01/22 | |
Polly Murphy
PRN | Corporate Officer/Principal | 59 | 09/09/20 |
Jeff Bova
PRN | Corporate Officer/Principal | - | 01/01/17 |
James Ottinger
LAW | General Counsel | - | 01/10/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 01/10/12 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 01/10/17 |
Fred Cohen
BRD | Director/Board Member | 67 | 16/05/17 |
Stuart Holden
BRD | Director/Board Member | 82 | 01/12/15 |
Chief Executive Officer | 62 | 03/01/19 | |
James Robinson
BRD | Director/Board Member | 54 | 25/07/23 |
Daniel Wildman
BRD | Director/Board Member | 68 | 08/11/22 |
Leana Wen
BRD | Director/Board Member | 41 | 12/09/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 36 130 121 | 32 257 075 ( 89,28 %) | 0 | 89,28 % |
Coordonnées société
UroGen Pharma Ltd.
400 Alexander Park Drive 4th floor
08540, Princeton
+(646) 768-9780
http://www.urogen.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-5,20% | 487 M | |
-1,65% | 103 Md | |
+6,75% | 101 Md | |
+5,71% | 23,07 Md | |
-12,60% | 22,23 Md | |
-9,70% | 18,05 Md | |
-39,98% | 17,18 Md | |
-10,17% | 16,94 Md | |
+6,12% | 14,07 Md | |
+35,47% | 12,35 Md |
- Bourse
- Actions
- Action URGN
- Société UroGen Pharma Ltd.